文献速递认知障碍与痴呆

血色病基因型与老年人痴呆发病的前瞻性研究

Haemochromatosis Genotypes and Incident Dementia in a Prospective Study of Older Adults.
PubMed 文献 · Neurology · 2025-05-29

本研究基于ASPREE试验中12,174名70岁以上欧洲裔健康老年人,评估HFE p.Cys282Tyr和p.His63Asp变异对血清铁蛋白及痴呆发病率的影响。中位随访6.4年显示,基线铁蛋白与痴呆风险无显著关联,但男性p.His63Asp+/+基因型者痴呆风险显著升高(调整HR=2.39,95%CI 1.25-4.57,p=0.009),女性中未观察到此关联。

要点

  • 男性HFE p.His63Asp纯合子与痴呆发病风险升高相关(调整HR=2.39)。
  • 基线血清铁蛋白水平与痴呆风险无显著关联。
  • 该遗传风险关联存在性别特异性,女性中未观察到。

核心结论

  • 在初始健康的老年男性中,HFE p.His63Asp纯合子与痴呆发病风险升高相关,女性中无此关联。

研究设计与样本

  • 前瞻性纵向研究,使用ASPREE试验数据,纳入12,174名无心血管疾病、痴呆或认知下降史的70岁以上欧洲裔健康老年人。
  • 中位随访6.4年,痴呆诊断由裁决委员会确认,采用微阵列进行HFE p.Cys282Tyr和p.His63Asp基因分型,基线血清铁蛋白用外周血样本测定。
  • 关联分析使用Cox比例风险模型并调整相关协变量。

主要发现

  • 男性p.Cys282Tyr+/+(p=0.048)和p.Cys282Tyr+/p.His63Asp+(p<0.001)基因型者基线铁蛋白水平显著高于野生型组。
  • 女性p.His63Asp+/+(p=0.015)和p.Cys282Tyr+/p.His63Asp+(p<0.001)基因型者铁蛋白水平亦升高。
  • 基线血清铁蛋白水平与痴呆风险无显著关联。
  • 男性p.His63Asp+/+基因型者痴呆发病风险显著升高(调整HR=2.39,95%CI 1.25-4.57,p=0.009),女性中未观察到此关联。

临床怎么用

  • 对于老年男性,HFE p.His63Asp纯合子可能作为痴呆风险分层的一个遗传标记,但需进一步验证。
  • 不推荐仅依据血清铁蛋白水平评估痴呆风险。

局限性

  • 研究仅纳入欧洲裔老年人,结果外推至其他人群需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Variants in the homeostatic iron regulator (HFE) gene are prevalent among individuals of European ancestry and have been linked to an increased risk of dementia. This study aimed to evaluate the effects of HFE p.Cys282Tyr and p.His63Asp variants on serum ferritin levels and the incidence of dementia in a cohort of initially healthy older adults. METHOD: This prospective longitudinal study used data from the Aspirin in Reducing Events in the Elderly trial. Participants had no history of cardiovascular disease, dementia, or cognitive decline at enrollment. Genotyping for HFE p.Cys282Tyr and p.His63Asp variants was conducted using microarrays, and baseline serum ferritin concentrations were measured in peripheral blood samples. Dementia diagnoses were confirmed by an adjudication committee over a median follow-up of 6.4 years. Associations were evaluated using Cox proportional hazards models adjusted for related covariates. RESULTS: The study included 12,174 unrelated, healthy participants of European ancestry aged 70 years or older, comprising 5,583 men (45.9%) and 6,591 women (54.1%). The median age was 73.7 years (interquartile range [IQR]: 71.6-76.9) for men and 73.9 years (IQR: 71.7-77.5) for women. Compared with the wild-type group, men with p.Cys282Tyr+/+ (p = 0.048) and p.Cys282Tyr+/p.His63Asp + genotypes (p < 0.001) had significantly higher baseline ferritin levels. Women with p.His63Asp+/+ (p = 0.015) and p.Cys282Tyr+/p.His63Asp+ (p < 0.001) genotypes also exhibited elevated ferritin levels. No significant association was observed between baseline serum ferritin levels and dementia risk. However, men with p.His63Asp+/+ genotype had a significantly higher risk of incident dementia (adjusted hazard ratio = 2.39, 95% CI 1.25-4.57, p = 0.009) compared with those without HFE variations. This association was not observed in women. DISCUSSION: Among initially healthy older adults, HFE p.His63Asp homozygosity was associated with a higher risk of incident dementia in men but not women. These findings highlight a potential sex-specific genetic risk factor for dementia and warrant further research into the underlying mechanisms linking p.His63Asp and dementia.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Yu C, Delatycki M, Hussain SM, et al. Haemochromatosis Genotypes and Incident Dementia in a Prospective Study of Older Adults. Neurology. 2025. PMID: 40440589. doi:10.1212/WNL.0000000000213743

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。